• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子 1α 和 CD147 在三阴性乳腺癌发展中的潜在机制。

The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.

机构信息

School of Medicine, Wuhan University of Science and Technology, Wuhan, People's Republic of China.

Department of Breast and Thyroid Surgery, Xiaogan Central Hospital and Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, People's Republic of China.

出版信息

Medicine (Baltimore). 2024 Jun 7;103(23):e38434. doi: 10.1097/MD.0000000000038434.

DOI:10.1097/MD.0000000000038434
PMID:38847725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11155533/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis, and the outcomes of common therapy were not favorable.

METHODS

The samples of 84 patients with TNBC and 40 patients with breast fibroadenoma were collected in the pathology department specimen library of our hospital. The prognosis of patients was obtained through outpatient follow-up information, telephone and WeChat contacts, and medical records. The mRNA expression was analyzed using bioinformation and quantitative real-time polymerase chain reaction (qPCR). The protein expression was determined by hematoxylin-eosin staining and immunohistochemical staining. The results of survival analysis were visualized using Kaplan-Meier curves.

RESULTS

The immunohistochemical staining showed that hypoxia-inducible factor-1alpha (HIF-1α) was mainly distributed in the nucleus and cytoplasm, while CD147 is mainly distributed in cell membrane and cytoplasm. The qPCR results exhibited that the expression level of HIF-1α and CD147 in TNBC tissue was significantly higher than that in breast fibroadenoma tissue. The expression of HIF-1α was related to the histological grade and lymph node metastasis in TNBC, and the expression of CD147 was related to Ki-67, histological grade and lymph node metastasis. There was a positive relationship between the expression of CD147 and HIF-1α. The upregulated expression of CD147 was closely related to the poor prognosis of OS in TNBC.

CONCLUSION

CD147 could be a biomarker for the prognosis of TNBC and closely related to the expression of HIF-1α.

摘要

背景

三阴性乳腺癌(TNBC)是一种预后较差的乳腺癌亚型,常规治疗效果并不理想。

方法

从我院病理科标本库收集了 84 例 TNBC 患者和 40 例乳腺纤维腺瘤患者的样本。通过门诊随访信息、电话和微信联系以及病历获得患者的预后情况。使用生物信息学和实时定量聚合酶链反应(qPCR)分析 mRNA 表达。通过苏木精-伊红染色和免疫组织化学染色测定蛋白表达。使用 Kaplan-Meier 曲线可视化生存分析结果。

结果

免疫组织化学染色显示缺氧诱导因子-1α(HIF-1α)主要分布在细胞核和细胞质中,而 CD147 主要分布在细胞膜和细胞质中。qPCR 结果显示,TNBC 组织中 HIF-1α 和 CD147 的表达水平明显高于乳腺纤维腺瘤组织。HIF-1α 的表达与 TNBC 的组织学分级和淋巴结转移有关,CD147 的表达与 Ki-67、组织学分级和淋巴结转移有关。CD147 的表达与 HIF-1α 呈正相关。CD147 的上调表达与 TNBC 的 OS 预后不良密切相关。

结论

CD147 可能是 TNBC 预后的生物标志物,与 HIF-1α 的表达密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/df8943f25bd2/medi-103-e38434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/6c6bf1d8d1c7/medi-103-e38434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/b262cb924e86/medi-103-e38434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/037f9fa382c3/medi-103-e38434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/9778157c2610/medi-103-e38434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/8dd43dcf0676/medi-103-e38434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/df8943f25bd2/medi-103-e38434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/6c6bf1d8d1c7/medi-103-e38434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/b262cb924e86/medi-103-e38434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/037f9fa382c3/medi-103-e38434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/9778157c2610/medi-103-e38434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/8dd43dcf0676/medi-103-e38434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a73/11155533/df8943f25bd2/medi-103-e38434-g006.jpg

相似文献

1
The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.缺氧诱导因子 1α 和 CD147 在三阴性乳腺癌发展中的潜在机制。
Medicine (Baltimore). 2024 Jun 7;103(23):e38434. doi: 10.1097/MD.0000000000038434.
2
Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.基于列线图模型联合HIF-1α和c-myc表达预测三阴性乳腺癌术后生存率
Medicine (Baltimore). 2019 Oct;98(40):e17370. doi: 10.1097/MD.0000000000017370.
3
The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.牛奶蛋白α-酪蛋白通过乳腺癌细胞和成纤维细胞中的 STAT 和 HIF-1α信号通路抑制三阴性乳腺癌干细胞活性。
J Mammary Gland Biol Neoplasia. 2019 Sep;24(3):245-256. doi: 10.1007/s10911-019-09435-1. Epub 2019 Sep 12.
4
Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.与其他乳腺癌分子亚型相比,三阴性乳腺癌中HIF-1α的表达和血管生成标志物无显著差异:对未来治疗的启示。
PLoS One. 2015 Jun 5;10(6):e0129356. doi: 10.1371/journal.pone.0129356. eCollection 2015.
5
Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α).长非编码 RNA(lncRNA)金属硫蛋白 1J,假基因(MT1JP)在三阴性乳腺癌中下调,并上调 microRNA-138(miR-138)下调缺氧诱导因子-1α(HIF-1α)。
Bioengineered. 2022 May;13(5):13718-13727. doi: 10.1080/21655979.2022.2077906.
6
CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.CD147 的表达与化疗治疗的三阴性乳腺癌患者的总体生存不良相关。
J Clin Pathol. 2018 Nov;71(11):1007-1014. doi: 10.1136/jclinpath-2018-205342. Epub 2018 Aug 11.
7
Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.缺氧诱导的三阴性乳腺癌自噬:与预后变量、患者生存和新辅助化疗反应的关系。
Virchows Arch. 2023 May;482(5):823-837. doi: 10.1007/s00428-023-03527-4. Epub 2023 Mar 20.
8
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.CD147 和 MMP-9 的高表达与三阴性乳腺癌 (TNBC) 患者的预后不良相关。
Med Oncol. 2013 Mar;30(1):335. doi: 10.1007/s12032-012-0335-4. Epub 2012 Dec 22.
9
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.靶向缺氧诱导因子-1α:三阴性乳腺癌治疗的新策略。
Biomed Pharmacother. 2022 Dec;156:113861. doi: 10.1016/j.biopha.2022.113861. Epub 2022 Oct 10.
10
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.miR-890 通过靶向 CD147 抑制三阴性乳腺癌细胞的增殖、侵袭并诱导其凋亡。
BMC Cancer. 2019 Jun 13;19(1):577. doi: 10.1186/s12885-019-5796-9.

本文引用的文献

1
Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis.CD276 和 CD147 之间的侧向相互作用对于乳腺癌的干性至关重要:来自近端蛋白质组分析的新见解。
Sci Rep. 2023 Aug 30;13(1):14242. doi: 10.1038/s41598-023-41416-7.
2
WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients.基于加权基因共表达网络分析(WGCNA)鉴定局部晚期乳腺癌患者治疗反应中的潜在靶点和通路。
Open Med (Wars). 2023 Mar 6;18(1):20230651. doi: 10.1515/med-2023-0651. eCollection 2023.
3
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.
环状指蛋白 31 通过抑制 YAP/PD-L1 抑制三阴性乳腺癌细胞的进展和免疫逃逸。
J Exp Clin Cancer Res. 2022 Dec 29;41(1):364. doi: 10.1186/s13046-022-02576-y.
4
Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials.铂类为基础的辅助治疗对三阴性乳腺癌有效:一项来自随机对照试验的荟萃分析。
Bioengineered. 2022 Jun;13(6):14827-14839. doi: 10.1080/21655979.2022.2115616.
5
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.靶向缺氧诱导因子-1α:三阴性乳腺癌治疗的新策略。
Biomed Pharmacother. 2022 Dec;156:113861. doi: 10.1016/j.biopha.2022.113861. Epub 2022 Oct 10.
6
The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.在常氧和缺氧条件下,阿霉素治疗前HIF-1α抑制对乳腺癌细胞的影响。
Exp Cell Res. 2022 Oct 15;419(2):113334. doi: 10.1016/j.yexcr.2022.113334. Epub 2022 Aug 28.
7
Interactions between Nitric Oxide and Hyaluronan Implicate the Migration of Breast Cancer Cells.一氧化氮与透明质酸的相互作用牵涉到乳腺癌细胞的迁移。
Biomacromolecules. 2022 Sep 12;23(9):3621-3647. doi: 10.1021/acs.biomac.2c00545. Epub 2022 Aug 3.
8
Efficacy and safety of palbociclib plus endocrine therapy for patients with HR/HER2 advanced breast cancer in real-world clinical practice.在真实世界临床实践中,帕博西尼联合内分泌治疗激素受体/人表皮生长因子受体2(HR/HER2)阳性晚期乳腺癌患者的疗效与安全性
Ann Transl Med. 2022 Mar;10(6):362. doi: 10.21037/atm-22-1002.
9
Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.通过综合分析研究基底型/TNBC 患者的候选基因和通路。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211019506. doi: 10.1177/15330338211019506.
10
MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.微小RNA-33a-5p过表达通过抑制真核翻译起始因子5A2和上皮-间质转化使三阴性乳腺癌对多柔比星敏感。
Oncol Lett. 2019 Dec;18(6):5986-5994. doi: 10.3892/ol.2019.10984. Epub 2019 Oct 14.